Skip to main content
Erschienen in: Archives of Dermatological Research 1/2017

18.11.2016 | Original Paper

Cytokeratin AE1/AE3 immunostaining and 3D-histology: improvement of diagnosis in desmoplastic squamous cell carcinoma of the skin

verfasst von: Katrin Schweinzer, Lukas Kofler, Jürgen Bauer, Gisela Metzler, Helmut Breuninger, Hans-Martin Häfner

Erschienen in: Archives of Dermatological Research | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Desmoplastic squamous cell carcinoma (DSCC) as a rare subtype of cutaneous SCC has specific histological features, characterized by columns, bands, and strands of squamoid cells infiltrating a dense collagenous stroma. To decrease the high rates of local recurrence in DSSC, improvement of diagnostic methods is highly demanded. Objective was to evaluate whether immunohistochemistry (IHC) is suited to increase diagnostic accuracy. A total number of 18 patients were included in this study. After recutting of the original paraffin blocks, parallel staining of serial sections with conventionally H&E and cytokeratin AE1/AE3-immunohistochemical staining was performed. Results were evaluated by an experienced dermatohistopathologist. In 55.6% (n = 10), the margins of 3D-histology still showed no evidence of neoplastic lesions in both stainings. In contrast, we found neoplastic lesions in 5 of 18 cases (27.8%) with cytokeratin AE1/AE3 staining, while H&E-staining remained negative. In addition, neoplastic lesions were found in both, H&E as well as cytokeratin AE1/AE3 staining in three cases (16.7%). The data presented show improvement of diagnosis in 27.8% of cases using IHC and 3D-histology. This method is suitable to improve the diagnosis of DSCC.
Literatur
1.
Zurück zum Zitat Allen JE, Stolle LB (2015) Utility of sentinel node biopsy in patients with high-risk cutaneous squamous cell carcinoma. Eur J Surg Oncol 41:197–200CrossRefPubMed Allen JE, Stolle LB (2015) Utility of sentinel node biopsy in patients with high-risk cutaneous squamous cell carcinoma. Eur J Surg Oncol 41:197–200CrossRefPubMed
2.
Zurück zum Zitat Boehringer A, Adam S, Schnabl S et al (2015) Analysis of incomplete excisions of basal-cell carcinomas after breadloaf microscopy compared with 3D-microscopy: a prospective randomized and blinded study. J Cutan Pathol 42:542–553CrossRefPubMed Boehringer A, Adam S, Schnabl S et al (2015) Analysis of incomplete excisions of basal-cell carcinomas after breadloaf microscopy compared with 3D-microscopy: a prospective randomized and blinded study. J Cutan Pathol 42:542–553CrossRefPubMed
3.
Zurück zum Zitat Brantsch KD, Meisner C, Schönfisch B et al (2008) Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol 9:713–720CrossRefPubMed Brantsch KD, Meisner C, Schönfisch B et al (2008) Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol 9:713–720CrossRefPubMed
4.
Zurück zum Zitat Breuninger H, Schaumburg-Lever G, Holzschuh J et al (1997) Desmoplastic squamous cell carcinoma of skin and vermilion surface: a highly malignant subtype of skin cancer. Cancer 79:915–919CrossRefPubMed Breuninger H, Schaumburg-Lever G, Holzschuh J et al (1997) Desmoplastic squamous cell carcinoma of skin and vermilion surface: a highly malignant subtype of skin cancer. Cancer 79:915–919CrossRefPubMed
5.
Zurück zum Zitat Buchanan L, De’Ambrosis B, De’Ambrosis K et al (2014) Defining incidental perineural invasion: the need for a national registry. Australas J Dermatol 55:107–110CrossRefPubMed Buchanan L, De’Ambrosis B, De’Ambrosis K et al (2014) Defining incidental perineural invasion: the need for a national registry. Australas J Dermatol 55:107–110CrossRefPubMed
6.
Zurück zum Zitat Carter JB, Johnson MM, Chua TL et al (2013) Outcomes of primary cutaneous squamous cell carcinoma with perineural invasion: an 11-year cohort study. JAMA Derm 149:35–41CrossRef Carter JB, Johnson MM, Chua TL et al (2013) Outcomes of primary cutaneous squamous cell carcinoma with perineural invasion: an 11-year cohort study. JAMA Derm 149:35–41CrossRef
7.
Zurück zum Zitat Chen S, Takahara M, Kido M et al (2008) Increased expression of an epidermal stem cell marker, cytokeratin 19, in cutaneous squamous cell carcinoma. Br J Derm 159:952–955CrossRef Chen S, Takahara M, Kido M et al (2008) Increased expression of an epidermal stem cell marker, cytokeratin 19, in cutaneous squamous cell carcinoma. Br J Derm 159:952–955CrossRef
8.
Zurück zum Zitat Frydenlund N, Leone DA, Mitchell B et al (2015) Perineural invasion in cutaneous squamous cell carcinoma: role of immunohistochemistry, anatomical site, and the high-affinity nerve growth factor receptor TrkA. Hum Path 46:1209–1216CrossRefPubMed Frydenlund N, Leone DA, Mitchell B et al (2015) Perineural invasion in cutaneous squamous cell carcinoma: role of immunohistochemistry, anatomical site, and the high-affinity nerve growth factor receptor TrkA. Hum Path 46:1209–1216CrossRefPubMed
9.
Zurück zum Zitat Genders RE, Bouwes Bavinck JN (2015) Sentinel lymph node biopsy for cutaneous squamous cell carcinoma: valuable or not valuable? Br J Dermatolatol 172:854–855CrossRef Genders RE, Bouwes Bavinck JN (2015) Sentinel lymph node biopsy for cutaneous squamous cell carcinoma: valuable or not valuable? Br J Dermatolatol 172:854–855CrossRef
10.
Zurück zum Zitat Goldenberg A, Ortiz A, Kim SS et al (2015) Squamous cell carcinoma with aggressive subclinical extension: 5-year retrospective review of diagnostic predictors. JAAD 73:120–126CrossRef Goldenberg A, Ortiz A, Kim SS et al (2015) Squamous cell carcinoma with aggressive subclinical extension: 5-year retrospective review of diagnostic predictors. JAAD 73:120–126CrossRef
11.
Zurück zum Zitat Gupta A, Veness M, De’Ambrosis B et al (2015) Management of squamous cell and basal cell carcinomas of the head and neck with perineural invasion. Australas J Dermatol 57:3–13CrossRefPubMed Gupta A, Veness M, De’Ambrosis B et al (2015) Management of squamous cell and basal cell carcinomas of the head and neck with perineural invasion. Australas J Dermatol 57:3–13CrossRefPubMed
12.
Zurück zum Zitat Gurda GT, Zhang L, Wang L et al (2015) Utility of five commonly used immunohistochemical markers TTF-1, napsin a, CK7, CK5/6 and P63 in primary and metastatic adenocarcinoma and squamous cell carcinoma of the lung: a retrospective study of 246 fine needle aspiration cases. Clin Transl Med 4:16CrossRefPubMedPubMedCentral Gurda GT, Zhang L, Wang L et al (2015) Utility of five commonly used immunohistochemical markers TTF-1, napsin a, CK7, CK5/6 and P63 in primary and metastatic adenocarcinoma and squamous cell carcinoma of the lung: a retrospective study of 246 fine needle aspiration cases. Clin Transl Med 4:16CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Haneke E (1989) Histologische varianten des plattenepithelkarzinoms der Haut und ihre diagnität. In: Breuninger H, Rassner G (eds) Fortschritte Der operativen dermatologie—operationsplanung und erfolgskontrolle, 5th edn. Springer, Heidelberg Haneke E (1989) Histologische varianten des plattenepithelkarzinoms der Haut und ihre diagnität. In: Breuninger H, Rassner G (eds) Fortschritte Der operativen dermatologie—operationsplanung und erfolgskontrolle, 5th edn. Springer, Heidelberg
14.
Zurück zum Zitat Häfner HM, Breuninger H, Möhrle M et al (2011) 3D histology-guided surgery for basal cell carcinoma and squamous cell carcinoma: recurrence rates and clinical outcome. Int J Oral Maxillofac Surg 40:943–948CrossRefPubMed Häfner HM, Breuninger H, Möhrle M et al (2011) 3D histology-guided surgery for basal cell carcinoma and squamous cell carcinoma: recurrence rates and clinical outcome. Int J Oral Maxillofac Surg 40:943–948CrossRefPubMed
15.
Zurück zum Zitat Jardim JF, Francisco ALN, Gondak R et al (2015) Prognostic impact of perineural invasion and lymphovascular invasion in advanced stage oral squamous cell carcinoma. Int J Oral Maxillofac Surg 44:23–28CrossRefPubMed Jardim JF, Francisco ALN, Gondak R et al (2015) Prognostic impact of perineural invasion and lymphovascular invasion in advanced stage oral squamous cell carcinoma. Int J Oral Maxillofac Surg 44:23–28CrossRefPubMed
16.
Zurück zum Zitat Krediet JT, Beyer M, Lenz K et al (2015) Sentinel lymph node biopsy and risk factors for predicting metastasis in cutaneous squamous cell carcinoma. Br J Dermatol 172:1029–1036CrossRefPubMed Krediet JT, Beyer M, Lenz K et al (2015) Sentinel lymph node biopsy and risk factors for predicting metastasis in cutaneous squamous cell carcinoma. Br J Dermatol 172:1029–1036CrossRefPubMed
17.
Zurück zum Zitat Matsushita Y, Yanamoto S, Takahasi H et al (2015) A clinicopathological study of perineural invasion and vascular invasion in oral tongue squamous cell carcinoma. Int J Oral Maxillofac Surg 44:543–548CrossRefPubMed Matsushita Y, Yanamoto S, Takahasi H et al (2015) A clinicopathological study of perineural invasion and vascular invasion in oral tongue squamous cell carcinoma. Int J Oral Maxillofac Surg 44:543–548CrossRefPubMed
18.
Zurück zum Zitat Miyagawa F, Hirose C, Fukumoto H et al (2015) Cutaneous squamous cell carcinoma with extensive perineural invasion and perineural cyst formation without regional lymph node metastases. J Dermatol 42:930–931CrossRefPubMed Miyagawa F, Hirose C, Fukumoto H et al (2015) Cutaneous squamous cell carcinoma with extensive perineural invasion and perineural cyst formation without regional lymph node metastases. J Dermatol 42:930–931CrossRefPubMed
19.
Zurück zum Zitat Moll R, Löwe A, Laufer J et al (1992) Cytokeratin 20 in human carcinomas. a new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 140:427–447PubMedPubMedCentral Moll R, Löwe A, Laufer J et al (1992) Cytokeratin 20 in human carcinomas. a new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 140:427–447PubMedPubMedCentral
20.
Zurück zum Zitat Petter G, Haustein UF (2000) Histologic subtyping and malignancy assessment of cutaneous squamous cell carcinoma. Dermatol Surg 26:521–530CrossRefPubMed Petter G, Haustein UF (2000) Histologic subtyping and malignancy assessment of cutaneous squamous cell carcinoma. Dermatol Surg 26:521–530CrossRefPubMed
21.
Zurück zum Zitat Sigel JE, Skacel M, Bergfeld WF et al (2001) The utility of cytokeratin 5/6 in the recognition of cutaneous spindle cell squamous cell carcinoma. J Cutan Pathol 28:520–524CrossRefPubMed Sigel JE, Skacel M, Bergfeld WF et al (2001) The utility of cytokeratin 5/6 in the recognition of cutaneous spindle cell squamous cell carcinoma. J Cutan Pathol 28:520–524CrossRefPubMed
22.
Zurück zum Zitat Velazquez EF, Werchniack AE, Granter SR (2010) Desmoplastic/spindle cell squamous cell carcinoma of the skin. a diagnostically challenging tumor mimicking a scar: clinicopathologic and immunohistochemical study of 6 cases. Am J Dermatopathol 32:333–339CrossRefPubMed Velazquez EF, Werchniack AE, Granter SR (2010) Desmoplastic/spindle cell squamous cell carcinoma of the skin. a diagnostically challenging tumor mimicking a scar: clinicopathologic and immunohistochemical study of 6 cases. Am J Dermatopathol 32:333–339CrossRefPubMed
23.
Zurück zum Zitat Warren TA, Panizza B, Porceddu SV et al (2014) Outcomes after surgery and postoperative radiotherapy for perineural spread of head and neck cutaneous squamous cell carcinoma. Head Neck 38:824–831CrossRef Warren TA, Panizza B, Porceddu SV et al (2014) Outcomes after surgery and postoperative radiotherapy for perineural spread of head and neck cutaneous squamous cell carcinoma. Head Neck 38:824–831CrossRef
Metadaten
Titel
Cytokeratin AE1/AE3 immunostaining and 3D-histology: improvement of diagnosis in desmoplastic squamous cell carcinoma of the skin
verfasst von
Katrin Schweinzer
Lukas Kofler
Jürgen Bauer
Gisela Metzler
Helmut Breuninger
Hans-Martin Häfner
Publikationsdatum
18.11.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Dermatological Research / Ausgabe 1/2017
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-016-1700-5

Weitere Artikel der Ausgabe 1/2017

Archives of Dermatological Research 1/2017 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.